GB8921222D0
(en)
*
|
1989-09-20 |
1989-11-08 |
Riker Laboratories Inc |
Medicinal aerosol formulations
|
IE67185B1
(en)
*
|
1990-02-02 |
1996-03-06 |
Fisons Plc |
Propellant compositions
|
US5118494A
(en)
*
|
1990-03-23 |
1992-06-02 |
Minnesota Mining And Manufacturing Company |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
IE912246A1
(en)
*
|
1990-06-28 |
1992-01-01 |
Glaxo Inc |
Aerosol drug formulations
|
US5126123A
(en)
*
|
1990-06-28 |
1992-06-30 |
Glaxo, Inc. |
Aerosol drug formulations
|
DK0536235T3
(da)
*
|
1990-06-29 |
1997-04-14 |
Fisons Plc |
Under tryk stående aerosolpræparater
|
US5292499A
(en)
*
|
1990-09-11 |
1994-03-08 |
University Of Wales College Of Cardiff |
Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
|
MX9203481A
(es)
*
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
US5919435A
(en)
*
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
HU205249B
(en)
*
|
1990-11-09 |
1992-04-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing suspensive aerosole composition
|
GB9024366D0
(en)
*
|
1990-11-09 |
1991-01-02 |
Glaxo Group Ltd |
Medicaments
|
GB9024365D0
(en)
*
|
1990-11-09 |
1991-01-02 |
Glaxo Group Ltd |
Medicaments
|
US5182097A
(en)
*
|
1991-02-14 |
1993-01-26 |
Virginia Commonwealth University |
Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
US5190029A
(en)
*
|
1991-02-14 |
1993-03-02 |
Virginia Commonwealth University |
Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
EP0504112A3
(en)
*
|
1991-03-14 |
1993-04-21 |
Ciba-Geigy Ag |
Pharmaceutical aerosol formulations
|
ATE203900T1
(de)
*
|
1991-06-10 |
2001-08-15 |
Schering Corp |
Fluorchlorkohlenwasserstofffreie aerosolformulierungen
|
US5474759A
(en)
†
|
1991-06-10 |
1995-12-12 |
Schering Corporation |
Non-chlorofluorocarbon aerosol formulations
|
WO1992022286A1
(en)
*
|
1991-06-12 |
1992-12-23 |
Minnesota Mining And Manufacturing Company |
Albuterol sulfate suspension aerosol formulations
|
NZ244439A
(en)
*
|
1991-09-25 |
1994-01-26 |
Fisons Plc |
Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
|
US6123924A
(en)
*
|
1991-09-25 |
2000-09-26 |
Fisons Plc |
Pressurized aerosol inhalation compositions
|
DE4132176C2
(de)
*
|
1991-09-27 |
1997-03-13 |
Ig Spruehtechnik Gmbh |
Dosieraerosole mit Isobutan als Treibmittel
|
GB9202522D0
(en)
*
|
1992-02-06 |
1992-03-25 |
Glaxo Group Ltd |
Medicaments
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5916540A
(en)
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
ATE128350T1
(de)
*
|
1991-12-12 |
1995-10-15 |
Glaxo Group Ltd |
Pharmazeutische aerosolformulierung.
|
IL104068A
(en)
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
DE69227257T2
(de)
|
1991-12-12 |
1999-03-25 |
Glaxo Group Ltd |
Arzneimittel
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
ES2159678T3
(es)
*
|
1991-12-18 |
2001-10-16 |
Minnesota Mining & Mfg |
Formulaciones de aerosol en suspension.
|
DK0550031T3
(da)
*
|
1991-12-31 |
1996-08-26 |
Solvay |
Medicinsk aerosolformulering
|
US5202110A
(en)
*
|
1992-01-22 |
1993-04-13 |
Virginia Commonwealth University |
Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants
|
DE4230876A1
(de)
*
|
1992-03-17 |
1993-09-23 |
Asta Medica Ag |
Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
|
DE4218291A1
(de)
*
|
1992-06-03 |
1993-12-09 |
Mattern Et Partner Pharmazeuti |
Dosierspray für pernasale Applikation
|
US5833950A
(en)
*
|
1992-07-31 |
1998-11-10 |
Glaxo Group Limited |
Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
|
MX9304585A
(es)
*
|
1992-07-31 |
1994-03-31 |
Glaxo Group Ltd |
Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
|
GR1001487B
(el)
*
|
1992-11-19 |
1994-02-28 |
Fisons Plc |
Πεπιεσμένες συν?έσεις αεροζόλης.
|
ES2064244B1
(es)
*
|
1992-12-02 |
1995-09-01 |
Fisons Plc |
Composiciones de aerosol presurizadas.
|
SG52459A1
(en)
*
|
1992-12-09 |
1998-09-28 |
Boehringer Ingelheim Pharma |
Stabilized medicinal aerosol solution formulations
|
US5458798A
(en)
|
1993-02-05 |
1995-10-17 |
E. I. Du Pont De Nemours And Company |
Azeotropic and azeotrope-like compositions of a hydrofluorocarbon and a hydrocarbon
|
US5492688A
(en)
*
|
1993-04-28 |
1996-02-20 |
The Center For Innovative Technology |
Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent
|
EP0697002B1
(en)
|
1993-04-30 |
1997-11-19 |
Minnesota Mining And Manufacturing Company |
Seal configuration for aerosol canister
|
DE4322703A1
(de)
|
1993-07-08 |
1995-01-12 |
Asta Medica Ag |
Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
|
DE4323636A1
(de)
*
|
1993-07-15 |
1995-01-19 |
Hoechst Ag |
Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
|
US5502076A
(en)
*
|
1994-03-08 |
1996-03-26 |
Hoffmann-La Roche Inc. |
Dispersing agents for use with hydrofluoroalkane propellants
|
US5508023A
(en)
*
|
1994-04-11 |
1996-04-16 |
The Center For Innovative Technology |
Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
|
HU214582B
(hu)
*
|
1994-07-26 |
1998-04-28 |
EGIS Gyógyszergyár Rt. |
Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
|
GB9419536D0
(en)
*
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US6932962B1
(en)
*
|
1994-12-22 |
2005-08-23 |
Astrazeneca Ab |
Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
|
US6013245A
(en)
*
|
1995-01-26 |
2000-01-11 |
Glaxo Group Limited |
Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
PT820322E
(pt)
|
1995-04-14 |
2002-10-31 |
Smithkline Beecham Corp |
Inalador com dosimetro para propionato de fluticasona
|
HUP9800641A3
(en)
|
1995-04-14 |
2001-04-28 |
Glaxo Wellcome Inc Res Triangl |
Metered dose inhaler for beclomethasone dipropionate
|
CZ296209B6
(cs)
*
|
1995-04-14 |
2006-02-15 |
Glaxo Wellcome Inc. |
Inhalátor a inhalacní systém
|
ATE219934T1
(de)
*
|
1995-04-14 |
2002-07-15 |
Smithkline Beecham Corp |
Dosierinhalator für albuterol
|
AU721566B2
(en)
*
|
1995-06-27 |
2000-07-06 |
Boehringer Ingelheim Kg |
New stable pharmaceutical preparation for producing propellant-free aerosols
|
GB9526392D0
(en)
*
|
1995-12-22 |
1996-02-21 |
Glaxo Group Ltd |
Medicaments
|
DE19616573C2
(de)
|
1996-04-25 |
1999-03-04 |
Pari Gmbh |
Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
|
GB9610341D0
(en)
*
|
1996-05-17 |
1996-07-24 |
Andaris Ltd |
Formulation for inhalation
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
US6039932A
(en)
*
|
1996-09-27 |
2000-03-21 |
3M Innovative Properties Company |
Medicinal inhalation aerosol formulations containing budesonide
|
GB9620187D0
(en)
†
|
1996-09-27 |
1996-11-13 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
US6461591B1
(en)
|
1997-02-05 |
2002-10-08 |
Jago Research Ag |
Medical aerosol formulations
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6120752A
(en)
*
|
1997-05-21 |
2000-09-19 |
3M Innovative Properties Company |
Medicinal aerosol products containing formulations of ciclesonide and related steroids
|
US20010031244A1
(en)
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
AU774250B2
(en)
*
|
1997-06-13 |
2004-06-24 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
GB2326334A
(en)
*
|
1997-06-13 |
1998-12-23 |
Chiesi Farma Spa |
Pharmaceutical aerosol compositions
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
EA002562B1
(ru)
*
|
1997-09-29 |
2002-06-27 |
Инхэл Терапьютик Системз, Инк. |
Перфорированные микрочастицы и способ их использования
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
WO1999016420A1
(en)
*
|
1997-09-29 |
1999-04-08 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in nebulizers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
ES2141049B1
(es)
*
|
1998-03-11 |
2000-10-16 |
Aldo Union S A Lab |
Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
|
GB9805938D0
(en)
|
1998-03-19 |
1998-05-13 |
Glaxo Group Ltd |
Valve for aerosol container
|
GB9807232D0
(en)
|
1998-04-03 |
1998-06-03 |
Univ Cardiff |
Aerosol composition
|
US6264923B1
(en)
|
1998-05-13 |
2001-07-24 |
3M Innovative Properties Company |
Medicinal aerosol formulation of ciclesonide and related compounds
|
US6423298B2
(en)
|
1998-06-18 |
2002-07-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
DE19827178A1
(de)
*
|
1998-06-18 |
2000-04-27 |
Boehringer Ingelheim Pharma |
Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
|
DK1087750T3
(da)
*
|
1998-06-18 |
2004-01-26 |
Boehringer Ingelheim Pharma |
Farmaceutiske formuleringer til aerosoler med to eller flere aktive stoffer
|
WO2000000215A1
(en)
*
|
1998-06-29 |
2000-01-06 |
Inhale Therapeutic Systems, Inc. |
Particulate delivery systems and methods of use
|
JP4570251B2
(ja)
|
1998-07-24 |
2010-10-27 |
ヤゴテック アーゲー |
医薬用エーロゾル製剤
|
NZ509489A
(en)
|
1998-08-04 |
2002-10-25 |
Jago Res A |
Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
|
IT1303788B1
(it)
|
1998-11-25 |
2001-02-23 |
Chiesi Farma Spa |
Formulazioni di aerosol medicinali.
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
US6630169B1
(en)
|
1999-03-31 |
2003-10-07 |
Nektar Therapeutics |
Particulate delivery systems and methods of use
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
IT1317904B1
(it)
*
|
1999-09-11 |
2003-07-15 |
Glaxo Group Ltd |
Formulazione farmaceutica di propionato di fluticasone.
|
FI20002217A
(fi)
*
|
1999-12-30 |
2001-07-01 |
Orion Yhtymae Oyj |
Inhalaatiopartikkelit
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
AU2001256168A1
(en)
|
2000-03-01 |
2001-09-12 |
Glaxo Group Limited |
Metered dose inhaler
|
EP1280520B2
(en)
|
2000-05-10 |
2018-03-21 |
Novartis AG |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
EA005179B1
(ru)
*
|
2000-05-22 |
2004-12-30 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Стабильные фармацевтические препараты в виде растворов для дозированных ингаляторов под давлением
|
US6451287B1
(en)
|
2000-05-26 |
2002-09-17 |
Smithkline Beecham Corporation |
Fluorinated copolymer surfactants and use thereof in aerosol compositions
|
GB0015043D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Medicament dispenser
|
US7141236B2
(en)
|
2000-07-28 |
2006-11-28 |
Nektar Therapeutics |
Methods and compositions for delivering macromolecules to or via the respiratory tract
|
JP2004509159A
(ja)
|
2000-09-22 |
2004-03-25 |
グラクソ グループ リミテッド |
新規なアルカン酸誘導体
|
AU2002215902A1
(en)
|
2000-10-13 |
2002-04-22 |
Glaxo Group Limited |
Medicament dispenser
|
MXPA03005697A
(es)
|
2000-12-22 |
2003-10-06 |
Glaxo Group Ltd |
Inhalador de dosis medida para xinafoato de salmeterol.
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
US20030072717A1
(en)
|
2001-02-23 |
2003-04-17 |
Vapotronics, Inc. |
Inhalation device having an optimized air flow path
|
TR200401980T4
(tr)
|
2001-07-02 |
2004-09-21 |
Chiesi Farmaceutici S.P.A. |
Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
GB0127989D0
(en)
|
2001-11-22 |
2002-01-16 |
Glaxo Group Ltd |
Medicament dispensing system
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
ATE508735T1
(de)
|
2001-12-19 |
2011-05-15 |
Novartis Ag |
Pulmonale verabreichung von aminoglykosiden
|
EP1467790A1
(en)
|
2002-01-25 |
2004-10-20 |
Glaxo Group Limited |
Medicament dispenser
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1471868A1
(en)
|
2002-01-30 |
2004-11-03 |
Glaxo Group Limited |
Compliance aid
|
EP1474376A1
(en)
|
2002-02-13 |
2004-11-10 |
Glaxo Group Limited |
Carboxylic acid compounds for use as surfactants
|
GB0205327D0
(en)
|
2002-03-06 |
2002-04-17 |
Glaxo Group Ltd |
compounds
|
JP2005533582A
(ja)
|
2002-07-25 |
2005-11-10 |
グラクソ グループ リミテッド |
薬剤ディスペンサ
|
WO2004052835A1
(en)
†
|
2002-12-10 |
2004-06-24 |
Sepracor Inc. |
Levalbuterol salt
|
GB0311701D0
(en)
*
|
2003-05-21 |
2003-06-25 |
Karib Kemi Pharm Liited |
Improved metered dose inhaler product
|
EP1635845A1
(en)
|
2003-06-13 |
2006-03-22 |
ALTANA Pharma AG |
Formoterol and ciclesonide combination
|
US7273603B2
(en)
|
2003-07-11 |
2007-09-25 |
Boehringer Ingelheim International Gmbh |
HFC solution formulations containing an anticholinergic
|
EP2275479A1
(en)
|
2003-08-11 |
2011-01-19 |
Glaxo Group Limited |
Pharmaceutical metered dose inhaler and methods relating thereto
|
CN1874756B
(zh)
|
2003-08-29 |
2012-02-29 |
葛兰素集团有限公司 |
药用计量剂量吸入器和其相关方法
|
DK1670482T4
(da)
|
2003-09-16 |
2022-08-22 |
Covis Pharma B V |
Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
EP1744800B1
(en)
|
2004-04-21 |
2016-06-22 |
Innovata Biomed Limited |
Inhaler
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
WO2007020204A2
(en)
*
|
2005-08-12 |
2007-02-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
|
GB0614621D0
(en)
|
2006-07-24 |
2006-08-30 |
3M Innovative Properties Co |
Metered dose dispensers
|
GB0620700D0
(en)
|
2006-10-19 |
2006-11-29 |
3M Innovative Properties Co |
Metered dose valves and dispensers
|
GB0621707D0
(en)
|
2006-10-31 |
2006-12-13 |
Univ London Pharmacy |
Formulations for delivery via pressurised metered dose inhalers
|
JP5825757B2
(ja)
|
2007-02-11 |
2015-12-02 |
マップ・ファーマシューティカルズ・インコーポレイテッド |
副作用プロファイルを最小限にしながら片頭痛の迅速な緩和を可能にするdheの治療上の投与方法
|
GB0712454D0
(en)
|
2007-06-27 |
2007-08-08 |
Generics Uk Ltd |
Pharmaceutical compositions
|
GB0716026D0
(en)
|
2007-08-16 |
2007-09-26 |
Norton Healthcare Ltd |
An inhalable medicament
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
US8652443B2
(en)
|
2008-02-14 |
2014-02-18 |
Precision Dermatology, Inc. |
Foamable microemulsion compositions for topical administration
|
JP2012514586A
(ja)
|
2009-01-05 |
2012-06-28 |
フラウンホーファーゲゼルシャフト ツール フォルデルング デル アンゲヴァンテン フォルシユング エー.フアー. |
Il−21およびil−21変異体に基づく抗体欠乏性疾患を治療するための手段および方法
|
JP5670421B2
(ja)
|
2009-03-31 |
2015-02-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
コンポーネント表面のコーティング方法
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
JP5658268B2
(ja)
|
2009-11-25 |
2015-01-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
KR101782306B1
(ko)
|
2009-11-25 |
2017-09-27 |
베링거 인겔하임 인터내셔날 게엠베하 |
분무기
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
WO2011150441A1
(en)
*
|
2010-06-03 |
2011-12-08 |
Wholesome Biopharm Pty Ltd |
Medical aerosol formulation comprising ribavirin
|
BR112012030930A2
(pt)
|
2010-06-04 |
2017-07-11 |
Trifoilium Aps |
fatores de trevo (tff) para tratamento de doenças pulmonares crônicas.
|
US9943654B2
(en)
|
2010-06-24 |
2018-04-17 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
RU2425691C1
(ru)
*
|
2010-07-15 |
2011-08-10 |
ВАКЕ спол с.р.о. |
Аэрозольный препарат на основе апротинина для лечения вирусных респираторных инфекций
|
RU2578975C2
(ru)
*
|
2010-08-03 |
2016-03-27 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы
|
SG188401A1
(en)
|
2010-09-09 |
2013-04-30 |
Trifoilium Aps |
Airway administration of angiogenesis inhibitors
|
TWI399202B
(zh)
*
|
2011-03-17 |
2013-06-21 |
Intech Biopharm Ltd |
製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
|
WO2012130757A1
(de)
|
2011-04-01 |
2012-10-04 |
Boehringer Ingelheim International Gmbh |
Medizinisches gerät mit behälter
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
JP2014519519A
(ja)
|
2011-06-15 |
2014-08-14 |
タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規3,4,4a,10b−テトラヒドロ−1H−チオピラノ[4,3−c]イソキノリン化合物
|
KR20140037195A
(ko)
|
2011-06-17 |
2014-03-26 |
다케다 게엠베하 |
신규 프탈라지논-피롤로피리미딘카복스아미드 유도체
|
BR112014003907A2
(pt)
|
2011-08-19 |
2017-06-13 |
Intech Biopharm Ltd. |
método para preparar inalador pulverizado de dose medida para tratar doença respiratória
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201117619D0
(en)
*
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201118188D0
(en)
|
2011-10-21 |
2011-12-07 |
3M Innovative Properties Co |
Manufacture of medicinal aerosol canisters
|
GB201200525D0
(en)
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
GB201210580D0
(en)
|
2012-06-14 |
2012-08-01 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
CN103520106A
(zh)
*
|
2012-07-02 |
2014-01-22 |
江苏山信药业有限公司 |
一种硫酸沙丁胺醇吸入气雾剂及其制备方法
|
GB201221063D0
(en)
|
2012-11-23 |
2013-01-09 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
GB201306984D0
(en)
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
ES2836977T3
(es)
|
2013-08-09 |
2021-06-28 |
Boehringer Ingelheim Int |
Nebulizador
|
EP3030298B1
(en)
|
2013-08-09 |
2017-10-11 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
KR102443739B1
(ko)
|
2014-05-07 |
2022-09-19 |
베링거 인겔하임 인터내셔날 게엠베하 |
분무기 및 컨테이너
|
ES2954961T3
(es)
|
2014-05-07 |
2023-11-27 |
Boehringer Ingelheim Int |
Unidad, nebulizador y método
|
HUE055604T2
(hu)
|
2014-05-07 |
2021-12-28 |
Boehringer Ingelheim Int |
Porlasztó
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
KR20170070151A
(ko)
|
2014-10-16 |
2017-06-21 |
테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 |
흡입형 제제
|
EP3383366B2
(en)
|
2015-12-04 |
2024-06-05 |
Mexichem Fluor S.A. de C.V. |
Pharmaceutical composition
|
AU2017328905C1
(en)
|
2016-09-19 |
2020-08-06 |
Mexichem Fluor S.A. De C.V. |
Pharmaceutical composition
|
BR112019005168A2
(pt)
|
2016-09-19 |
2019-06-11 |
Mexichem Fluor Sa De Cv |
composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica
|
CN114272238A
(zh)
|
2016-09-19 |
2022-04-05 |
墨西哥氟石股份公司 |
药物组合物
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|
AU2019209502B2
(en)
|
2018-01-18 |
2022-05-12 |
Humboldt-Universität Zu Berlin |
Langerin+ Cell Targeting
|
WO2024079352A1
(en)
|
2022-10-14 |
2024-04-18 |
Cutanos Gmbh |
Lipid nanoparticle formulations for mrna delivery to langerhans cells
|